Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:387  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1Synthesis of Novel Quaternary Ammonium Salts and Their in Vitro Antileishmanial Activity and U-937 Cell Cytotoxicity
Sandra Duque-Benítez,Luz Ríos-Vásquez,Rogelio Ocampo-Cardona,David Cedeño,Marjorie Jones,Iván Vélez,Sara Robledo
Molecules.2016;21(4)381
[DOI]
2Innate Immunity and Leishmania Vaccination Strategies
Ron Birnbaum,Noah Craft
Dermatologic Clinics.2011;29(1)89
[DOI]
3Vaccination model for visceral leishmaniasis with infective immigrants
Ibrahim M. ELmojtaba,J.Y.T. Mugisha,Mohsin H.A. Hashim
Mathematical Methods in the Applied Sciences.2013;36(2)216
[DOI]
4Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens
Leticia H. Higa,Laura Arnal,Mónica Vermeulen,Ana Paula Perez,Priscila Schilrreff,Cecilia Mundiña-Weilenmann,Osvaldo Yantorno,María Elena Vela,María José Morilla,Eder Lilia Romero,Bhaskar Saha
PLOS ONE.2016;11(3)e0150185
[DOI]
5IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis
Ciara Gimblet,Michael A. Loesche,Lucas Carvalho,Edgar M. Carvalho,Elizabeth A. Grice,David Artis,Phillip Scott,Simona Stäger
PLOS ONE.2015;10(8)e0134698
[DOI]
6Immune signal transduction in leishmaniasis from natural to artificial systems: Role of feedback loop insertion
Milsee Mol,Milind S. Patole,Shailza Singh
Biochimica et Biophysica Acta (BBA) - General Subjects.2014;1840(1)71
[DOI]
7Leishmaniasis: complexity at the host–pathogen interface
Paul Kaye,Phillip Scott
Nature Reviews Microbiology.2011;9(8)604
[DOI]
8Ethanolic leaf extract of Coccinia grandis is effective against both drug resistant and drug sensitive clinical isolates of Indian Kala-azar
Sangita Lahiry,Anjan K. Das,Sachindra N. Das,Madhumita Manna
Journal of Parasitic Diseases.2018;42(3)433
[DOI]
9Attenuated Leishmania induce pro-inflammatory mediators and influence leishmanicidal activity by p38 MAPK dependent phagosome maturation in Leishmania donovani co-infected macrophages
Somenath Banerjee,Dipayan Bose,Nabanita Chatterjee,Subhadip Das,Sreeparna Chakraborty,Tanya Das,Krishna Das Saha
Scientific Reports.2016;6(1)433
[DOI]
10Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach
Manju Kashyap,Varun Jaiswal,Umar Farooq
Infection, Genetics and Evolution.2017;53(1)107
[DOI]
11Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection
S.A. Campbell,J. Alawa,B. Doro,F.L. Henriquez,C.W. Roberts,A. Nok,C.B.I. Alawa,M. Alsaadi,A.B. Mullen,K.C. Carter
Vaccine.2012;30(7)1357
[DOI]
12Enlarging the chemical space of anti-leishmanials: a structure–activity relationship study of peptoids against Leishmania mexicana, a causative agent of cutaneous leishmaniasis
H. L. Bolt,G. A. Eggimann,Paul W. Denny,Steven L. Cobb
MedChemComm.2016;7(5)799
[DOI]
13Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Guillermo Arango Duque,Albert Descoteaux
Frontiers in Immunology.2014;5(5)799
[DOI]
14Proteome-scale identification of Leishmania infantum for novel vaccine candidates: A hierarchical subtractive approach
Bahareh Vakili,Navid Nezafat,Gholam Reza Hatam,Bijan Zare,Nasrollah Erfani,Younes Ghasemi
Computational Biology and Chemistry.2018;72(5)16
[DOI]
15A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum
L. Pirdel,S. Farajnia
Scandinavian Journal of Immunology.2017;86(1)15
[DOI]
16A Single Haplotype of IFNG Correlating With Low Circulating Levels of Interferon-? Is Associated With Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis
George A V da Silva,Tirza G Mesquita,Victor C Souza,José do Espírito Santo Junior,Mara Lúcia Gomes de Souza,Anette Chrusciak Talhari,Sinésio Talhari,Felipe G Naveca,Rajendranath Ramasawmy
Clinical Infectious Diseases.2019;86(1)15
[DOI]
17Innate immunity againstLeishmaniainfections
Prajwal Gurung,Thirumala-Devi Kanneganti
Cellular Microbiology.2015;17(9)1286
[DOI]
18Innate immunity againstLeishmaniainfections
Shishir K. Gupta,Thomas Dandekar
Cellular Microbiology.2018;17(9)297
[DOI]
19Th17 cells and neutrophils: Close collaborators in chronicLeishmania mexicanainfections leading to disease severity
C. P. Pedraza-Zamora,J. Delgado-Domínguez,J. Zamora-Chimal,I. Becker
Parasite Immunology.2017;39(4)e12420
[DOI]
20Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms
Pedro A. Martinez,Christine A. Petersen
Immunologic Research.2014;59(1-3)153
[DOI]
21Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms
Dulcilene Mayrink de Oliveira,Jonatan Marques Campos,Soraia de Oliveira Silva,Maria Norma Melo
Immunologic Research.2019;59(1-3)153
[DOI]
22Pomegranate (Punica granatum) Juice Shows Antioxidant Activity against Cutaneous Leishmaniasis-Induced Oxidative Stress in Female BALB/c Mice
Badriah Alkathiri,Manal El-Khadragy,Dina Metwally,Ebtesam Al-Olayan,Muhammed Bakhrebah,Ahmed Abdel Moneim
International Journal of Environmental Research and Public Health.2017;14(12)1592
[DOI]
23Countervailing, time-dependent effects on host autophagy promote intracellular survival ofLeishmania
Sneha A. Thomas,Devki Nandan,Jennifer Kass,Neil E. Reiner
Journal of Biological Chemistry.2018;293(7)2617
[DOI]
24Actualités sur les leishmanioses viscérales
B. Faucher,R. Piarroux
La Revue de Médecine Interne.2011;32(9)544
[DOI]
25A polymorphism in the IL1B gene (rs16944 T/C) is associated with cutaneous leishmaniasis caused by Leishmania guyanensis and plasma cytokine interleukin receptor antagonist
George Allan Villarouco da Silva,Tirza Gabrielle Ramos de Mesquita,Helia Valeria de Souza Encarnação,José do Espírito Santo Junior,Karolina da Costa Sabino,Isaac de Aguiar Neres,Salim Assad de Almeida,Mara Lúcia Gomes de Souza,Sinésio Talhari,Rajendranath Ramasawmy
Cytokine.2019;123(9)154788
[DOI]
26A polymorphism in the IL1B gene (rs16944 T/C) is associated with cutaneous leishmaniasis caused by Leishmania guyanensis and plasma cytokine interleukin receptor antagonist
Pedro Cecílio,Fabiano Oliveira,Anabela Cordeiro da Silva
Cytokine.2018;123(9)154788
[DOI]
27Investigating the Anti-leishmanial Effects of Linear Peptoids
Gabriela A. Eggimann,Hannah L. Bolt,Paul W. Denny,Steven L. Cobb
ChemMedChem.2015;10(2)233
[DOI]
28Intralesional uridine-5'-triphosphate (UTP) treatment induced resistance to Leishmania amazonensis infection by boosting Th1 immune responses and reactive oxygen species production
Camila Marques-da-Silva,Mariana M. Chaves,Maria Luiza Thorstenberg,Vanessa R. Figliuolo,Flávia S. Vieira,Suzana P. Chaves,José Roberto Meyer-Fernandes,Bartira Rossi-Bergmann,Luiz Eduardo Baggio Savio,Robson Coutinho-Silva
Purinergic Signalling.2018;14(2)201
[DOI]
29Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro
Adil M. Allahverdiyev,Emrah Sefik Abamor,Melahat Bagirova,Serap Yesilkir Baydar,Sezen Canim Ates,Figen Kaya,Cengiz Kaya,Miriam Rafailovich
Experimental Parasitology.2013;135(1)55
[DOI]
30FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases
Fariborz Bahrami,Haiedeh Darabi,Farhad Riazi-Rad,Vahid Khaze,Soheila Ajdary,Mohammad Hossein Alimohammadian
Human Immunology.2014;75(10)1026
[DOI]
31FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases
Bhavana Sethu Lakshmi,Rentala Madhubala
Human Immunology.2013;75(10)143
[DOI]
32Identifying miltefosine-resistant key genes in protein–protein interactions network and experimental verification in Iranian Leishmania major
Niloofar Lari,Razieh Jalal,Zarrin Minuchehr,Majid Rajabian Noghondar
Molecular Biology Reports.2019;46(5)5371
[DOI]
33Leishmaniasis cutánea
Julián Díaz Sánchez,Sagrario Barrientos Serrano,Silvia Morell Mañas
FMC - Formación Médica Continuada en Atención Primaria.2012;19(3)117
[DOI]
34Exploring the Role of Medicinal Plant-Based Immunomodulators for Effective Therapy of Leishmaniasis
Garima Chouhan,Mohammad Islamuddin,Dinkar Sahal,Farhat Afrin
Frontiers in Immunology.2014;5(3)117
[DOI]
35An NLRP3 inflammasome–triggered Th2-biased adaptive immune response promotes leishmaniasis
Prajwal Gurung,Rajendra Karki,Peter Vogel,Makiko Watanabe,Mark Bix,Mohamed Lamkanfi,Thirumala-Devi Kanneganti
Journal of Clinical Investigation.2015;125(3)1329
[DOI]
36Leishmania donovani inhibits inflammasome-dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2
Anand Kumar Gupta,Kuntal Ghosh,Shreyasi Palit,Jayita Barua,Pijush K. Das,Anindita Ukil
The FASEB Journal.2017;31(11)5087
[DOI]
37Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana
Salma Jamal,Vinod Scaria
BMC Bioinformatics.2013;14(1)5087
[DOI]
38Apoptotic induction induces Leishmania aethiopica and L. mexicana spreading in terminally differentiated THP-1 cells
RAJEEV RAI,PAUL DYER,SIMON RICHARDSON,LAURENCE HARBIGE,GIULIA GETTI
Parasitology.2017;144(14)1912
[DOI]
39A Perspective on the Emergence of Sialic Acids as Potent Determinants AffectingLeishmaniaBiology
Angana Ghoshal,Chitra Mandal
Molecular Biology International.2011;2011(14)1
[DOI]
40Immunogenicity and Efficacy of Polytope DNA Vaccine Against Cutaneous Leishmaniosis In Vivo
Reza Keikha,Mojgan Bandehpour,Shabnam Jeibouei,Bahram Kazemi
Health Scope.2017;7(1)1
[DOI]
41Head-to-Head Comparison of Three Vaccination Strategies Based on DNA and Raw Insect-Derived Recombinant Proteins against Leishmania
Felicitat Todolí,Alhelí Rodríguez-Cortés,María del Carmen Núñez,Márcia D. Laurenti,Silvia Gómez-Sebastián,Fernando Rodríguez,Eva Pérez-Martín,José M. Escribano,Jordi Alberola,Anil Kumar Tyagi
PLoS ONE.2012;7(12)e51181
[DOI]
42Nucleolar Localization of RNA Binding Proteins Induced by Actinomycin D and Heat Shock in Trypanosoma cruzi
Ezequiel Názer,Ramiro E. Verdún,Daniel O. Sánchez,Mauricio Martins Rodrigues
PLoS ONE.2011;6(5)e19920
[DOI]
43A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells
Mithun Maji,Saumyabrata Mazumder,Souparno Bhattacharya,Somsubhra Thakur Choudhury,Abdus Sabur,Md. Shadab,Pradyot Bhattacharya,Nahid Ali
Scientific Reports.2016;6(1)e19920
[DOI]
44A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells
Joachim Kloehn,Eleanor C. Saunders,Malcolm J. McConville
Scientific Reports.2016;6(1)83
[DOI]
45Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium
Igor Grekov,Milena Svobodová,Eva Nohýnková,Marie Lipoldová
Journal of Microbiological Methods.2011;87(3)273
[DOI]
46The impact of distinct culture media in Leishmania infantum biology and infectivity
NUNO SANTARÉM,JOANA CUNHA,RICARDO SILVESTRE,CÁTIA SILVA,DIANA MOREIRA,MARC OUELLETTE,ANABELA CORDEIRO-DA-SILVA
Parasitology.2014;141(2)192
[DOI]
47A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study
Jyoti Joshi,Nancy Malla,Sukhbir Kaur
Parasitology International.2014;63(4)612
[DOI]
48A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study
Angela Casini,Andreia de Almeida
Parasitology International.2016;63(4)297
[DOI]
49Anti-parasitic Peptides from Arthropods and their Application in Drug Therapy
Ariane F. Lacerda,Patrícia B. Pelegrini,Daiane M. de Oliveira,Érico A. R. Vasconcelos,Maria F. Grossi-de-Sá
Frontiers in Microbiology.2016;7(4)297
[DOI]
50Leishmania recombinant antigen modulates macrophage effector function facilitating early clearance of intracellular parasites
Anuradha Ratna,Sunil K Arora
Transactions of The Royal Society of Tropical Medicine and Hygiene.2016;110(10)610
[DOI]
51Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis
Toni Aebischer
Frontiers in Immunology.2014;5(10)610
[DOI]
52ANIMAL MODELS FOR THE STUDY OF LEISHMANIASIS IMMUNOLOGY
Elsy Nalleli Loria-Cervera,Fernando Jose Andrade-Narvaez
Revista do Instituto de Medicina Tropical de São Paulo.2014;56(1)1
[DOI]
53Interactions betweenLeishmania braziliensisand Macrophages Are Dependent on the Cytoskeleton and Myosin Va
Elisama Azevedo,Leandro Teixeira Oliveira,Ana Karina Castro Lima,Rodrigo Terra,Patrícia Maria Lourenço Dutra,Verônica P. Salerno
Journal of Parasitology Research.2012;2012(1)1
[DOI]
54GTPase Sar1 regulates the trafficking and secretion of the virulence factor gp63 inLeishmania
Smriti Parashar,Amitabha Mukhopadhyay
Journal of Biological Chemistry.2017;292(29)12111
[DOI]
55Nigella sativa oil entrapped polycaprolactone nanoparticles for leishmaniasis treatment
Emrah Sefik Abamor,Ozlem Ayse Tosyali,Melahat Bagirova,Adil Allahverdiyev
IET Nanobiotechnology.2018;12(8)1018
[DOI]
56Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Angamuthu Selvapandiyan,Ranadhir Dey,Sreenivas Gannavaram,Ines Lakhal-Naouar,Robert Duncan,Poonam Salotra,Hira L. Nakhasi
Journal of Tropical Medicine.2012;2012(8)1
[DOI]
57Interactions of antiparasitic alkaloids withLeishmaniaprotein targets: a molecular docking analysis
Ifedayo Victor Ogungbe,Joseph D Ng,William N Setzer
Future Medicinal Chemistry.2013;5(15)1777
[DOI]
58Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
Negar Seyed,Tahereh Taheri,Charline Vauchy,Magalie Dosset,Yann Godet,Ali Eslamifar,Iraj Sharifi,Olivier Adotevi,Christophe Borg,Pierre Simon Rohrlich,Sima Rafati,Clive M. Gray
PLoS ONE.2014;9(10)e108848
[DOI]
59Identifying vaccine targets for anti-leishmanial vaccine development
Shyam Sundar,Bhawana Singh
Expert Review of Vaccines.2014;13(4)489
[DOI]
60Single Dose Novel Salmonella Vaccine Enhances Resistance against Visceralizing L. major and L. donovani Infection in Susceptible BALB/c Mice
Juliane Schroeder,Najmeeyah Brown,Paul Kaye,Toni Aebischer,Diane McMahon-Pratt
PLoS Neglected Tropical Diseases.2011;5(12)e1406
[DOI]
61Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis
Sajad Rashidi,Kurosh Kalantar,Gholamreza Hatam
Journal of Parasitic Diseases.2018;42(2)162
[DOI]
62Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends
Ali Badiee,Vahid Heravi Shargh,Ali Khamesipour,Mahmoud Reza Jaafari
Vaccine.2013;31(5)735
[DOI]
63Protozoan Parasites Glycosylphosphatidylinositol Anchors: Structures, Functions and Trends for Drug Discovery
Ana Luísa Malaco Morotti,Maristela Braga Martins-Teixeira,Ivone Carvalho
Current Medicinal Chemistry.2019;26(23)4301
[DOI]
64TLR-mediated distinct IFN-?/IL-10 pattern induces protective immunity against murine visceral leishmaniasis
Joydeep Paul,Subir Karmakar,Tripti De
European Journal of Immunology.2012;42(8)2087
[DOI]
65In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
Negar Seyed,Farnaz Zahedifard,Shima Safaiyan,Elham Gholami,Fatemeh Doustdari,Kayhan Azadmanesh,Maryam Mirzaei,Nasir Saeedi Eslami,Akbar Khadem Sadegh,Ali Eslami far,Iraj Sharifi,Sima Rafati,Hechmi Louzir
PLoS Neglected Tropical Diseases.2011;5(9)e1295
[DOI]
66Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
Dirlei Nico,Daniele Crespo Gomes,Marcus Vinícius Alves-Silva,Elisangela Oliveira Freitas,Alexandre Morrot,Diana Bahia,Marcos Palatnik,Mauricio M. Rodrigues,Clarisa B. Palatnik-de-Sousa
Frontiers in Immunology.2014;5(9)e1295
[DOI]
67Efficacy of Recombinant Canine Distemper Virus Expressing Leishmania Antigen against Leishmania Challenge in Dogs
Ryuichi Miura,Takanori Kooriyama,Misako Yoneda,Akiko Takenaka,Miho Doki,Yasuyuki Goto,Chizu Sanjoba,Yasuyuki Endo,Tomoko Fujiyuki,Akihiro Sugai,Kyoko Tsukiyama-Kohara,Yoshitsugu Matsumoto,Hiroki Sato,Chieko Kai,Ricardo Toshio Fujiwara
PLOS Neglected Tropical Diseases.2015;9(7)e0003914
[DOI]
68Identification and expression of a new member of the pyrokinin/pban gene family in the sand fly Phlebotomus papatasi
Man-Yeon Choi,Neil D. Sanscrainte,Alden S. Estep,Robert K. Vander Meer,James J. Becnel
Journal of Insect Physiology.2015;79(7)55
[DOI]
69Proteoliposomes in nanobiotechnology
P. Ciancaglini,A. M. S. Simão,M. Bolean,J. L. Millán,C. F. Rigos,J. S. Yoneda,M. C. Colhone,R. G. Stabeli
Biophysical Reviews.2012;4(1)67
[DOI]
70Substrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14a-Demethylase (CYP51) fromLeishmania infantum
Tatiana Y. Hargrove,Zdzislaw Wawrzak,Jialin Liu,W. David Nes,Michael R. Waterman,Galina I. Lepesheva
Journal of Biological Chemistry.2011;286(30)26838
[DOI]
71Substrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14a-Demethylase (CYP51) fromLeishmania infantum
Ranadhir Dey,Sreenivas Gannavaram,Angamuthu Selvapandiyan,Jacqueline Fiuza,Robert Duncan,Hira L. Nakhasi
Journal of Biological Chemistry.2014;286(30)45
[DOI]
72Immunization against Leishmania major Infection Using LACK- and IL-12-Expressing Lactococcus lactis Induces Delay in Footpad Swelling
Felix Hugentobler,Karen K. Yam,Joshua Gillard,Raya Mahbuba,Martin Olivier,Benoit Cousineau,Dan Zilberstein
PLoS ONE.2012;7(2)e30945
[DOI]
73Metabolomic Analyses of Leishmania Reveal Multiple Species Differences and Large Differences in Amino Acid Metabolism
Gareth D. Westrop,Roderick A. M. Williams,Lijie Wang,Tong Zhang,David G. Watson,Ana Marta Silva,Graham H. Coombs,Bhaskar Saha
PLOS ONE.2015;10(9)e0136891
[DOI]
74Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis
Bhavana Sethu Lakshmi,Ruobing Wang,Rentala Madhubala
Vaccine.2014;32(30)3816
[DOI]
75Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches
Sumit Joshi,Keerti Rawat,Narendra Kumar Yadav,Vikash Kumar,Mohammad Imran Siddiqi,Anuradha Dube
Frontiers in Immunology.2014;5(30)3816
[DOI]
76Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection
Felix Hugentobler,Raphaël B. Di Roberto,Joshua Gillard,Benoit Cousineau
Vaccine.2012;30(39)5726
[DOI]
77Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection
Ifedayo V. Ogungbe,Meenakshi Singh,William N. Setzer
Vaccine.2012;36(39)331
[DOI]
78Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host response
Amartya Mishra,Jayaraman Vinayagam,Sourav Saha,Sayan Chowdhury,Somenath Roychowdhury,Parasuraman Jaisankar,Hemanta K. Majumder
Pharmacology Research & Perspectives.2014;2(6)e00070
[DOI]
79Development of a new live attenuated Leishmania major p27 gene knockout: Safety and immunogenicity evaluation in BALB/c mice
Samira Elikaee,Mehdi Mohebali,Sassan Rezaei,Hamid Eslami,Ali Khamesipour,Hossein Keshavarz,Mohammad Reza Eshraghian
Cellular Immunology.2018;332(6)24
[DOI]
80Comparison of immunogenical potency of Leishmania major (MRHO/IR/75/ER) antigens prepared by 3 different methods in conjunction with Alum-Naltrexone adjuvant in BALB/c mice
Peyman Khezri,Shahram Shahabi,Esmaeil Abasi,Habib Mohammadzadeh Hajipirloo
Alexandria Journal of Medicine.2018;54(4)503
[DOI]
81Novel Betulin Derivatives as Antileishmanial Agents with Mode of Action Targeting Type IB DNA Topoisomerase
Sayan Chowdhury,Tulika Mukherjee,Souvik Sengupta,Somenath Roy Chowdhury,Sibabrata Mukhopadhyay,Hemanta K. Majumder
Molecular Pharmacology.2011;80(4)694
[DOI]
82Proteome Profiling of Human Cutaneous Leishmaniasis Lesion
Claire da Silva Santos,Sanaz Attarha,Ravi Kanth Saini,Viviane Boaventura,Jackson Costa,Ricardo Khouri,Manoel Barral-Netto,Cláudia Ida Brodskyn,Serhiy Souchelnytskyi
Journal of Investigative Dermatology.2015;135(2)400
[DOI]
83Metabolic Variation during Development in Culture of Leishmania donovani Promastigotes
Ana Marta Silva,Anabela Cordeiro-da-Silva,Graham H. Coombs,Genevieve Milon
PLoS Neglected Tropical Diseases.2011;5(12)e1451
[DOI]
84Leishmania tarentolaeexpressing CXCL-10 as an efficient immunotherapy approach againstLeishmania major-infected BALB/c mice
H. Montakhab-Yeganeh,Z. Abdossamadi,F. Zahedifard,Y. Taslimi,A. Badirzadeh,N. Saljoughian,T. Taheri,M. Taghikhani,S. Rafati
Parasite Immunology.2017;39(10)e12461
[DOI]
85Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya
Ahmad Amro,Hamida Al-Dwibe,Aisha Gashout,Olga Moskalenko,Marlena Galafin,Omar Hamarsheh,Marcus Frohme,Anja Jaeschke,Gabriele Schönian,Katrin Kuhls,Anne-Laure Bañuls
PLOS Neglected Tropical Diseases.2017;11(9)e0005873
[DOI]
86Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study
Sara khalili,Elahe Ebrahimzade,Mehdi Mohebali,Parviz Shayan,Samira Mohammadi-Yeganeh,Mehrdad Moosazadeh Moghaddam,Samira Elikaee,Behnaz Akhoundi,Mohammad Kazem Sharifi-Yazdi
Experimental Parasitology.2019;196(9)48
[DOI]
87Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection
A. M. SILVA,J. TAVARES,R. SILVESTRE,A. OUAISSI,G. H. COOMBS,A. CORDEIRO-da-SILVA
Parasite Immunology.2012;34(6)345
[DOI]
88Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
Maria Agallou,Evita Athanasiou,Olga Koutsoni,Eleni Dotsika,Evdokia Karagouni
Frontiers in Immunology.2014;5(6)345
[DOI]
89Alternative to Chemotherapy—The Unmet Demand against Leishmaniasis
Nicky Didwania,Md. Shadab,Abdus Sabur,Nahid Ali
Frontiers in Immunology.2017;8(6)345
[DOI]
90The Economic Value of a Visceral Leishmaniasis Vaccine in Bihar State, India
Diana L. Connor,Rachel B. Slayton,Mirat Shah,Sara Beth Kitchen,Bruce Y. Lee,Kristina M. Bacon
The American Journal of Tropical Medicine and Hygiene.2012;86(3)417
[DOI]
91Application of nanotechnology in treatment of leishmaniasis: A Review
Maryam Akbari,Ahmad Oryan,Gholamreza Hatam
Acta Tropica.2017;172(3)86
[DOI]
92Cytosolic Recognition of Microbes and Pathogens: Inflammasomes in Action
Jenni A. Hayward,Anukriti Mathur,Chinh Ngo,Si Ming Man
Microbiology and Molecular Biology Reviews.2018;82(4)86
[DOI]
93KSAC, a Defined Leishmania Antigen, plus Adjuvant Protects against the Virulence of L. major Transmitted by Its Natural Vector Phlebotomus duboscqi
Regis Gomes,Clarissa Teixeira,Fabiano Oliveira,Phillip G. Lawyer,Dia-Eldin Elnaiem,Claudio Meneses,Yasuyuki Goto,Ajay Bhatia,Randall F. Howard,Steven G. Reed,Jesus G. Valenzuela,Shaden Kamhawi,Ben L. Kelly
PLoS Neglected Tropical Diseases.2012;6(4)e1610
[DOI]
94Liposomal Elongation Factor-1a Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis
Abdus Sabur,Sudipta Bhowmick,Rudra Chhajer,Sarfaraz Ahmad Ejazi,Nicky Didwania,Mohammad Asad,Anirban Bhattacharyya,Utsa Sinha,Nahid Ali
Frontiers in Immunology.2018;9(4)e1610
[DOI]
95Visceral leishmaniasis: An overview of vaccine adjuvants and their applications
Sneha Ratnapriya,Sneha Keerti,Amogh A. Sahasrabuddhe,Anuradha Dube
Vaccine.2019;37(27)3505
[DOI]
96Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity
A. K. Marr,S. Cen,R. E. W. Hancock,W. R. McMaster
Antimicrobial Agents and Chemotherapy.2016;60(4)2484
[DOI]
97Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors
Prajwal Gurung,Thirumala-Devi Kanneganti
Cellular and Molecular Life Sciences.2016;73(16)3035
[DOI]
98Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis
Sneha Anand,Rentala Madhubala
Scientific Reports.2015;5(1)3035
[DOI]
99Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments
Shubhranshu Zutshi,Sunil Kumar,Prashant Chauhan,Yashwant Bansode,Arathi Nair,Somenath Roy,Arup Sarkar,Bhaskar Saha
Vaccines.2019;7(4)156
[DOI]
100Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
REBECCA L. CHARLTON,BARTIRA ROSSI-BERGMANN,PAUL W. DENNY,PATRICK G. STEEL
Parasitology.2018;145(2)219
[DOI]
101Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents
Penta Ashok,Subhash Chander,Terry K. Smith,Rajnish Prakash Singh,Prabhat Nath Jha,Murugesan Sankaranarayanan
Bioorganic Chemistry.2019;84(2)98
[DOI]
102Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents
Vincent R. Bonagura
Bioorganic Chemistry.2014;84(2)845
[DOI]
103Visceral leishmaniasis: immunology and prospects for a vaccine
P.M. Kaye,T. Aebischer
Clinical Microbiology and Infection.2011;17(10)1462
[DOI]
104Leishmania infantum Asparagine Synthetase A Is Dispensable for Parasites Survival and Infectivity
Joana Faria,Inês Loureiro,Nuno Santarém,Sandra Macedo-Ribeiro,Joana Tavares,Anabela Cordeiro-da-Silva,Michael Pollastri
PLOS Neglected Tropical Diseases.2016;10(1)e0004365
[DOI]
105Leishmaniasis in the Middle East: Incidence and Epidemiology
Nasir Salam,Waleed Mohammed Al-Shaqha,Arezki Azzi,Elodie Ghedin
PLoS Neglected Tropical Diseases.2014;8(10)e3208
[DOI]
  Addresses 
  My Preferences 


JGID
JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008